Dr. Voodoo,
Thanks for dropping by. I'm glad to get an informed opinion on the Nanokan systems. They cost $5 million. So it's understandable that pharmas' case of the capex slows -- whatever its cause -- is a problem. From a contrarian perspective, however . . . the spigot is expected to turn on in a couple of months (if you get any signals about this, feel free to share). Thus I expect DPII to come on strong in the second half, last Q in particular. I am very close to getting Trickle back in.
I presume you are referring to the entire article, of which the following is the abstract via MedLine:
>>Solid-phase combinatorial synthesis using MicroKan reactors, Rf tagging, and directed sorting.
Biotechnol Bioeng 2000 Winter;71(1):44-50 (ISSN: 0006-3592)
Xiao XY; Li R; Zhuang H; Ewing B; Karunaratne K; Lillig J; Brown R; Nicolaou KC [Find other articles with these Authors] IRORI, a Discovery Partners International Company, 9640 Towne Centre Drive, San Diego, California 92121, USA.
A modular system for high-output solid-phase combinatorial synthesis has been designed and developed. The system employs three technological innovations to achieve its high efficiency and reliability: (1) application of microreactors as the reaction units in solid-phase synthesis; (2) use of radiofrequency tagging as the non-chemical tracking method; and (3) development of the directed sorting technology for split & pool synthesis. The system has been successfully applied in the synthesis of compound libraries of several hundred to several thousand compounds in multi-milligrams per compound quantity by many organizations.<<
snip
Cheers, Tuck |
